Eksigent Announces Major Expansion for HPLC Manufacturing and Service
Eksigent Technologies announced that it will increase manufacturing capacity by 40 percent to meet strong demand for its HPLC products.
"The need for this increase in product build capability is being driven by higher than expected customer demand for both our cHiPLC®-nanoflex for proteomics, introduced in February of this year, and our ExpressHT-Ultra HPLC System for ADME-Tox and DMPK studies, introduced last fall," stated David Neyer, vice president and co-founder of Eksigent. "We are also actively recruiting for field service personnel to ensure that customer installations are maintained at our traditionally short lead times."
Eksigent's Board of Directors approved spending last month for additional equipment, tools and staff. "Fortunately, the plant space was available to immediately accommodate this expansion, which will be complete next month," said Wade Guindy, Eksigent vice president of R&D, engineering and operations.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Entire T-cell receptor repertoire sequenced revealing extensive and unshared diversity
Chiral Technologies Europe Acquires ChromTech Ltd. of U.K.
Aviation safety: Rapid test for harmful microbes in kerosene developed - Faster and more robust than a PCR test
Next generation solar fuels: How a record-breaking copper catalyst converts CO₂ into liquid fuels - Researchers have made real-time movies of copper nanoparticles as they evolve to convert carbon dioxide and water into renewable fuels and chemicals
Phenomenex: Zebron GC Columns Receive Two R&D 100 Awards
Rapid detection of antibiotic-resistant bacteria
Scientists create a DNA test that identifies Lyme disease in horses - A test under development by a Rutgers professor could have applications for humans and dogs, too
Neutrino detector starts measurement - New facility in France to measure fundamental properties of neutrinos
Analytik Jena Wins New Orders in China
New technology used to construct the first map of structural variation in the human genome - Methods also applicable to disease diagnosis, drug response tests
